Proto-Oncogene Proteins c-ets
"Proto-Oncogene Proteins c-ets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of transcription factors that share a unique DNA-binding domain. The name derives from viral oncogene-derived protein oncogene protein v-ets of the AVIAN ERYTHROBLASTOSIS VIRUS.
| Descriptor ID |
D050783
|
| MeSH Number(s) |
D12.776.260.665 D12.776.624.664.700.175 D12.776.930.720
|
| Concept/Terms |
Proto-Oncogene Proteins c-ets- Proto-Oncogene Proteins c-ets
- Proto Oncogene Proteins c ets
- c-ets, Proto-Oncogene Proteins
- Proto-Oncogene Protein ets
- Proto Oncogene Protein ets
- ets Transcription Factors
- Transcription Factors, ets
- c-ets Proto-Oncogene Proteins
- Proto-Oncogene Proteins, c-ets
- c ets Proto Oncogene Proteins
- ets Proto-Oncogene Proteins
- Proto-Oncogene Proteins, ets
- ets Proto Oncogene Proteins
- c-ets Protein
- c ets Protein
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-ets".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-ets".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-ets" by people in this website by year, and whether "Proto-Oncogene Proteins c-ets" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-ets" by people in Profiles.
-
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations. Blood Adv. 2022 08 09; 6(15):4357-4359.
-
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Reports. 2021 06 08; 16(6):1458-1467.
-
Collaborative repressive action of the antagonistic ETS transcription factors Pointed and Yan fine-tunes gene expression to confer robustness in Drosophila. Development. 2018 07 02; 145(13).
-
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol. 2018 04 01; 36(10):991-999.
-
Germline ETV6 mutations and predisposition to hematological malignancies. Int J Hematol. 2017 Aug; 106(2):189-195.
-
Multiple layers of transcriptional regulation by PLZF in NKT-cell development. Proc Natl Acad Sci U S A. 2016 07 05; 113(27):7602-7.
-
ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis. Blood. 2015 Nov 12; 126(20):2344-5.
-
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015 Feb; 47(2):180-5.
-
Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics. 2013 Sep; 23(9):470-8.
-
PPARG binding landscapes in macrophages suggest a genome-wide contribution of PU.1 to divergent PPARG binding in human and mouse. PLoS One. 2012; 7(10):e48102.